Surmodics to Present at 5th Annual InvestMNt Conference on August 24

August 16, 2016 at 8:06 AM EDT

Webcast is Live at 8:30 a.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Aug. 16, 2016-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that the Company will present at the 2016 InvestMNt conference sponsored by CFA Society Minnesota.

The two-day event will take place August 23-24 at the University of St. Thomas in downtown Minneapolis. Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and chief financial officer, will present on Wednesday, August 24, at 8:30 a.m. CT (9:30 a.m. ET). The presentation will be webcast live by MeetMax and can be accessed by registering at www.investMNt.org.

A total of 80 companies from the Upper Midwest and elsewhere are participating in the conference, which is sponsored by the 1,300-member CFA Society and financially supported by more than 30 institutional investment firms and corporate sponsors. For more information and to register, visit www.investMNt.org.

About Surmodics, Inc.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) tests and microarrays. Following two recent acquisitions of Creagh Medical and NorMedix, the company is executing a key growth strategy for its medical device business by expanding to offer total intravascular product solutions to its medical device customers. The combination of proprietary surface technologies, along with enhanced device design, development and manufacturing capabilities, enables Surmodics to significantly increase the value it offers with highly differentiated intravascular solutions designed and engineered to meet the most demanding requirements. With this focus on offering total product solutions, Surmodics’ mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information about the company, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

About InvestMNt

Now in its fifth year, InvestMNt is a two-day conference developed by institutional investors at mutual funds, private money management firms, retirement plan sponsors and other wealth management entities. Last year's event featured C-level executives from 53 presenting companies, plus more than 200 one-on-one meetings with senior management. More than 400 people attended last year's event, which was conceived and implemented by the CFA Society Minnesota.

About CFA Society Minnesota

Founded in 1952, CFA Society Minnesota is one of the oldest chapters of prestigious CFA Institute, issuer of the Chartered Financial Analyst® Designation. CFA Society Minnesota is the 23rd largest society among the 145 member societies and affiliates worldwide. For more than 60 years, CFA Society Minnesota has endeavored to play a vital role within the Twin Cities investment community.

Source: Surmodics, Inc.

Surmodics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com